Procedure Guide


Indications

  • Massive hemoptysis = >240 mL/24hr (~1 cup) -> emergent BAE

  • Crescendo hemoptysis / Major hemorrhagic hemoptysis = >2 episodes with >100 mL in 24 hr or >100 mL/24 hr for multiple days -> urgent BAE

  • Moderate hemoptysis (debated) = 50-100 mL/24 hrs + FEV1 < 40% -> possible elective BAE

  • Often associated with bronchiectasis, aspergillosis, TB, or chronic PNA


Contraindications

No absolute contraindication though underlying coagulopathy should be corrected if present to try to achieve INR <1.7 and Plt >50K.


Efficacy and alternatives

  • High mortality from conservative treatment due to asphyxiation 

  • Recurrence after BAE 2-27% early likely due to incomplete embolization of non-bronchial feeding vessels and 10-52% long term via recanalization. It can be safely repeated though becomes more technically challenging with greater likelihood of non-bronchial arterial supply.


Pre-procedure care

  • CTA chest to delineate anatomy and identify a target: bronchial artery >>> pulm artery

    • Bronchial arteries often arise from the aorta at T3-T8, often T5/6. However, up to 20% have ectopic bronchial arteries from subclavian, internal mammary, etc. Often no active extravasation but can see tortuous, enlarged bronchial artery to target.

    • Caldwell branching types: (1, 41%) common right intercostobrachial artery trunk and two left; (2, 21%) same as 1 but single left; (3, 21%) right intercostobronchial trunk plus second right and two left; (4, 10%) same as 3 but single left

    • Think about rarer pulmonary arterial source if h/o Swan Ganz or TB with traumatic or Rasmussen PsA

  • *Bronchoscopy* found to not be helpful - identifies site of bleed in <50%, endobronchial therapies tend to be ineffective and delays BAE

    • NOT RECOMMENDED per 2014 ACR Appropriateness Criteria and 2010 Cystic Fibrosis Foundation Expert panel

  • CBC, INR/Coags, Cr, ECG, Type & screen

  • NPO except medication 6 hrs prior if possible. Often good to have anesthesia support for respiratory monitoring.


procedure

  • Femoral or radial arterial access 

  • Advance flush catheter into descending thoracic aorta and perform run if anatomy not already delineated on CTA

  • Select bronchial arteries/intercostobrachial trunk (often from descending thoracic Ao at T5-T6), often SOS, Simmons, or Mikaelsson, and perform run

    • If arising from undersurface of arch - Judkins left coronary (JL) catheter can be helpful

    • If arising from right side wall of arch - Rosch hepatic (RH) catheter can be helpful

    • If arising steeply from descending aorta with shared origin with contralateral bronchial - can cut a side hole near tip of microcatheter, extend into one bronchial, and advance wire out the side hole into the other

  • Advance microwire/microcatheter system to select abnormal vessel. Often only abnormal vascularity and parenchymal blush seen rather than extravasation.

    • If normal, think about pulmonary artery supply of bleeding, particularly is history of TB or Swan-Ganz

    • Watch out for anterior spine artery, which can arise from the bronchial artery but more commonly seem from right intercostal > left intercostal > right bronchointercostal > left bronchointercostal, left thyrocervical, right costocervical. Classically courses back towards midline with hairpin turn.

  • Embolize, most commonly with >325 um particles.

    • Most common = 350-500 um PVA but tends to clump

    • Embospheres can be used but may want larger size to avoid infarction. Must also rule out right to left shunting that can lead to stroke.

    • Liquid embolics can save time and potentially has less recurrence but requires experience to use. Many use a thicker 1:2 glue-lipiodol ratio.

    • Coils traditionally avoided but data from Japan suggests superselective coil embolization is equally effective with potentially less risk of spinal ischemia. 

  • Select and treat other bronchial and non-bronchial arteries as needed.

  • Access closure


Complications

Transient chest pain/dysphagia is common and often self-limited

Spinal cord ischemia (old data suggested 1-6% but some data pre microcatheters)

*BAE does NOT accelerate deterioration in lung function*


Post-procedure care & Follow Up

Often return care to primary ICU team for continued close hemodynamic monitoring.